Posted in | News | Display

MicroVision to Highlight PicoP Display Technology-Based Engines at 2014 CES

MicroVision, Inc., a leader in innovative, ultra-miniature projection display technology, today announced it will be attending the 2014 Consumer Electronics Show (CES) in Las Vegas.

The company will be hosting meetings with consumer electronics Original Equipment Manufacturers (OEMs) to show new and exciting product concept devices to showcase the possibilities enabled by PicoP® display technology that excite consumers – offering a convenient and dynamic way to view media-rich content on the go. These devices integrate the latest generation of PicoP display technology, which enables a bright, high definition, always in focus image from a small form factor. The company will also feature display engines from its partners that highlight its award-winning PicoP display technology.

MicroVision recently conducted focus groups for mobile devices equipped with PicoP display technology. The participants, who represented a range of demographic profiles, were shown demonstrations with devices similar to those that will be featured by MicroVision at CES. The experience of enhanced viewing of movies, sports and social media images garnered extremely positive reactions, and participants were impressed with the image quality, convenience and ease of use that these PicoP-enabled devices demonstrated. The ability of PicoP display technology to create a big screen experience from a handheld, portable device that never required focusing was seen as a capability that would increase usage of mobile devices for video viewing.

MicroVision is engaged in discussions with targeted OEMs for bringing PicoP display technology to market in their products. Under its licensing business model, the company is also working with multiple partners with the goal of having supply sources for display engines based on PicoP display technology readily available for OEMs.

About MicroVision

MicroVision is the creator of PicoP® display technology, an ultra-miniature laser projection solution for mobile consumer electronics, automotive head-up displays and other applications. MicroVision’s patented display technology helps OEMs break down display boundaries and offer enhanced visibility to mobile experiences. Nearly two decades of research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision’s IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and is also included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Wash. For more information, visit the company’s website at www.microvision.com, on Facebook at www.facebook.com/MicroVisionInc or follow MicroVision on Twitter at @MicroVision.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Microvision. (2019, February 26). MicroVision to Highlight PicoP Display Technology-Based Engines at 2014 CES. AZoOptics. Retrieved on November 21, 2024 from https://www.azooptics.com/News.aspx?newsID=18345.

  • MLA

    Microvision. "MicroVision to Highlight PicoP Display Technology-Based Engines at 2014 CES". AZoOptics. 21 November 2024. <https://www.azooptics.com/News.aspx?newsID=18345>.

  • Chicago

    Microvision. "MicroVision to Highlight PicoP Display Technology-Based Engines at 2014 CES". AZoOptics. https://www.azooptics.com/News.aspx?newsID=18345. (accessed November 21, 2024).

  • Harvard

    Microvision. 2019. MicroVision to Highlight PicoP Display Technology-Based Engines at 2014 CES. AZoOptics, viewed 21 November 2024, https://www.azooptics.com/News.aspx?newsID=18345.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.